Liberty Wealth Management LLC Beam Therapeutics Inc. Transaction History

Liberty Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$68.02 - $99.06 $68,020 - $99,060	-1,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$64.12 - $128.71 $8.19 Million - $16.4 Million	-127,710 Reduced 99.22%	1,000 $129,000
Q2 2021 Aug 13, 2021	BUY	$64.12 - $128.71 $8.19 Million - $16.4 Million	127,710 Added 12771.0%	128,710 $1 Million
Q3 2020 Nov 05, 2020	BUY	$19.0 - $30.57 $19,000 - $30,570	1,000 New	1,000 $25,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.